Project Optimus: Sponsors Register Concerns, Questions

Meeting requests related to the Oncology Center of Excellence’s new dose optimization approach are increasing, along with sponsor questions, prompting the US FDA to determine how to clarify its intentions.

cancer therapy preparation
Sponsors still have many questions about Project Optimus. • Source: Shutterstock

SAN DIEGO – US Food and Drug Administration officials are finding that demanding dose-finding studies earlier in development is not as easy as it may appear in a policy document.

Key Takeaways

  • OCE’s Angelo De Claro said sponsors are unclear about many aspects of the center’s dose optimization program.

Angelo De Claro, associate director for global clinical sciences in the FDA Oncology Center of Excellence, said sponsors continue to...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from DIA

More from Conferences